Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morisada Hayakawa

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 7, 2024
Cure of Congenital Purpura Fulminans via Expression of Engineered Protein C Through Neonatal Genome Editing in MiceTomoki Togashi, Nemekhbayar Baatartsogt, Yasumitsu Nagao, et al.
Blood Advances|October 4, 2023
Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia ATakafumi Hiramoto, Hiroshi Inaba, Nemekhbayar Baatartsogt, et al.
Scientific Reports|July 8, 2022
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in miceHideki Ishikawa, Morisada Hayakawa, Nemekhbayar Baatartsogt, et al.
Scientific Reports|July 22, 2021
Characterization and visualization of murine coagulation factor VIII-producing cells in vivoMorisada Hayakawa, Asuka Sakata, Hiroko Hayakawa, et al.
Communications Medicine|April 19, 2023
PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cellsTakafumi Hiramoto, Yuji Kashiwakura, Morisada Hayakawa, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2026
Non-viral delivery of a base editor enables personalized correction of hemophilia B nonsense variants in a mouse modelUchina Hiya-Kawaguchi, Yuji Kashiwakura, Nemekhbayar Baatartsogt, et al.
The Journal of Rheumatology|November 18, 2009
Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritisYasushi Matsuyama, Hitoaki Okazaki, Hiroyuki Tamemoto, et al.
Blood|November 6, 2025
Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapyYuji Kashiwakura, Yuto Nakajima, Kio Horinaka, et al.
Blood|October 23, 2025
Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia BNemekhbayar Baatartsogt, Yuji Kashiwakura, Takafumi Hiramoto, et al.
The Journal of Biological Chemistry|December 25, 2016
Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell InductionMorisada Hayakawa, Hiroko Hayakawa, Tsvetana Petrova, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Arteriosclerosis, Thrombosis, and Vascular Biology|November 7, 2024
Cure of Congenital Purpura Fulminans via Expression of Engineered Protein C Through Neonatal Genome Editing in MiceTomoki Togashi, Nemekhbayar Baatartsogt, Yasumitsu Nagao, et al.
Blood Advances|October 4, 2023
Genome editing of patient-derived iPSCs identifies a deep intronic variant causing aberrant splicing in hemophilia ATakafumi Hiramoto, Hiroshi Inaba, Nemekhbayar Baatartsogt, et al.
Scientific Reports|July 8, 2022
IκBζ regulates the development of nonalcoholic fatty liver disease through the attenuation of hepatic steatosis in miceHideki Ishikawa, Morisada Hayakawa, Nemekhbayar Baatartsogt, et al.
Scientific Reports|July 22, 2021
Characterization and visualization of murine coagulation factor VIII-producing cells in vivoMorisada Hayakawa, Asuka Sakata, Hiroko Hayakawa, et al.
Communications Medicine|April 19, 2023
PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cellsTakafumi Hiramoto, Yuji Kashiwakura, Morisada Hayakawa, et al.
Journal of Thrombosis and Haemostasis : JTH|June 11, 2026
Non-viral delivery of a base editor enables personalized correction of hemophilia B nonsense variants in a mouse modelUchina Hiya-Kawaguchi, Yuji Kashiwakura, Nemekhbayar Baatartsogt, et al.
The Journal of Rheumatology|November 18, 2009
Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritisYasushi Matsuyama, Hitoaki Okazaki, Hiroyuki Tamemoto, et al.
Blood|November 6, 2025
Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapyYuji Kashiwakura, Yuto Nakajima, Kio Horinaka, et al.
Blood|October 23, 2025
Therapeutic base editing to generate a gain-of-function F9 variant for hemophilia BNemekhbayar Baatartsogt, Yuji Kashiwakura, Takafumi Hiramoto, et al.
The Journal of Biological Chemistry|December 25, 2016
Loss of Functionally Redundant p38 Isoforms in T Cells Enhances Regulatory T Cell InductionMorisada Hayakawa, Hiroko Hayakawa, Tsvetana Petrova, et al.
Pageof 4